Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breast cancer
breast cancer
This Cancer Drug's News Could Mean Another Blockbuster for AstraZeneca
Motley Fool
Tue, 06/14/22 - 11:42 am
AstraZeneca
breast cancer
Enhertu
ASCO22: Enhertu aces key HER2-low test in breast cancer
Pharmaforum
Mon, 06/6/22 - 09:43 am
ASCO 2022
AstraZeneca
Daiichi Sankyo
Enhertu
HER2-low breast cancer
breast cancer
ASCO: Gilead's Trodelvy limps forward in new breast cancer lane as below-par showing casts doubt
Fierce Pharma
Sun, 06/5/22 - 11:42 pm
Gilead Sciences
Trodelvy
breast cancer
ASCO 2022
ASCO: Pfizer's Ibrance fails to extend lives in newly diagnosed breast cancer. Will doctors switch gears to Novartis, Lilly?
Fierce Pharma
Sun, 06/5/22 - 11:40 pm
ASCO 2022
Pfizer
Ibrance
HR-positive
HER2-negative breast cancer
breast cancer
clinical trials
At ESMO, three studies show promise of antibody-drug conjugates in breast cancer
Pharmaforum
Mon, 05/30/22 - 10:23 am
ESMO
breast cancer
antibody-drug conjugate
AstraZeneca
Seagen's potential breast cancer blockbuster Tukysa shows promise in colorectal cancer
Fierce Pharma
Mon, 05/23/22 - 06:46 pm
Seagen
Tukysa
breast cancer
colorectal cancer
clinical trials
FDA Approves AstraZeneca, Daiichi Sankyo’s ENHERTU in Breast Cancer
Contract Pharma
Thu, 05/5/22 - 10:40 am
AstraZeneca
Daiichi Sankyo
Enhertu
FDA
HER2+ breast cancer
breast cancer
FDA clears wearable 3D ultrasound for breast imaging
MedCity News
Tue, 05/3/22 - 10:32 pm
devices
Medtech
FDA
iSono Health
ultrasound
breast imaging
breast cancer
Roche’s oral SERD giredestrant fails breast cancer trial
Pharmaforum
Mon, 04/25/22 - 10:48 am
Roche
breast cancer
SERD
Giredestrant
clinical trials
Gilead's Immunomedics settles over-hyped ASCO data mishap for $4M
Endpoints
Mon, 04/18/22 - 10:44 am
Immunomedics
Gilead Sciences
ASCO
breast cancer
Seagen scores $41.8M in Enhertu patent case against Daiichi Sankyo
Fierce Pharma
Mon, 04/11/22 - 11:00 am
Seagen
Daiichi Sankyo
patents
breast cancer
Enhertu
BriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trial
BioSpace
Thu, 04/7/22 - 10:39 am
BriaCell
breast cancer
Bria-OTS
immunotherapy
Long wait for pivotal data on Sanofi's oral SERD ends in failure
Fierce Biotech
Mon, 03/14/22 - 10:32 am
Sanofi
Amcenestrant
Serds
breast cancer
clinical trials
That key Gilead breast cancer readout? Try 2024, and don't get your hopes up: analyst
Fierce Pharma
Wed, 03/9/22 - 10:51 am
Gilead Sciences
Trodelvy
breast cancer
Gilead says breast cancer drug succeeded in key study, but offers few details
BioPharma Dive
Mon, 03/7/22 - 10:52 pm
Gilead Sciences
Trodelvy
clinical trials
M&A
breast cancer
Big day for AZ, Daiichi as Enhertu aces HER2-low breast cancer trial
Pharmaforum
Mon, 02/21/22 - 10:35 am
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
HER2-low breast cancer
breast cancer
Radius falters after a PhIII osteoporosis fail and a breast cancer disappointment, sending shares plummeting
Endpoints
Thu, 12/9/21 - 10:56 am
Radius Health
clinical trials
osteoporosis
breast cancer
Tymlos
Sanofi hit by filing delays for key drugs, drops an early Sangamo thalassemia asset
Fierce Biotech
Thu, 10/28/21 - 10:40 am
Sanofi
earnings
fitusiran
Sangamo
breast cancer
Trial For World’s First Potential Breast Cancer Vaccine Begins
BioSpace
Wed, 10/27/21 - 12:21 pm
breast cancer
vaccines
clinical trials
Anixa Biosciences
Cleveland Clinic
Seagen’s breast cancer drug Tukysa turned down by NICE
Pharmaforum
Tue, 10/26/21 - 10:36 am
NICE
Seagen
breast cancer
Tukysa
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »